Thompson Donald Orofacial Myologist is categorized under Speech Pathologists in Phoenix, AZ and active since 2003.
Thompson Donald Orofacial Myologist was established in 2003, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Speech Pathologists business, which does work in the B2C market, and is classified as a Speech Pathologists, under code number 621340 by the NAICS.
If you are seeking more information, feel free to contact Donald Thompson at the company’s single location by writing to 6245 North 35th Avenue # 8, Phoenix, Arizona AZ 85017 or by phoning (904) 764-5618. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Thompson Donald Orofacial Myologist |
| Contact Person: | Donald Thompson |
| Address: | 6245 North 35th Avenue # 8, Phoenix, Arizona 85017 |
| Phone Number: | (904) 764-5618 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Speech Pathologists |
| SIC Code: | 8049 |
| NAICS Code: | 621340 |
| Share This Business: |
Thompson Donald Orofacial Myologist was started in 2003 to provide professional Speech Pathologists under the SIC code 8049 and NAICS code 621340. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Donald Thompson for inquiries that concern Thompson Donald Orofacial Myologist by calling the company number (904) 764-5618, as your correspondence is most welcome. Additionally, the physical location of the single location of Thompson Donald Orofacial Myologist can be found at the coordinates as well as the street address 6245 North 35th Avenue # 8 in Phoenix, Arizona 85017.
For its online presence, you may visit Thompson Donald Orofacial Myologist’s website at and engage with its social media outlets through on Twitter and on Facebook.